How does renal impairment typically affect clearance of renally eliminated drugs?

Get ready for the MDC Pharmacokinetics (PK) II Exam. Study with flashcards and multiple choice questions, each offering hints and explanations. Excel in your exam preparation!

Multiple Choice

How does renal impairment typically affect clearance of renally eliminated drugs?

Explanation:
Renal clearance of drugs that are eliminated by the kidney depends on kidney function. When renal function is reduced, CrCl falls, so the renal clearance (Clr) decreases. With lower clearance, the body removes the drug more slowly, causing the elimination half-life to increase and overall exposure (AUC) at a given dose to rise. To keep the steady-state concentration (Css) at the desired level, you must lower the dose or extend the dosing interval (or do both). In short, renal impairment typically reduces clearance of renally eliminated drugs and requires dose or interval adjustments to maintain Css. Some drugs also have non-renal clearance channels, but the main point remains: diminished kidney function lowers clearance and can lead to accumulation if dosing isn’t adjusted.

Renal clearance of drugs that are eliminated by the kidney depends on kidney function. When renal function is reduced, CrCl falls, so the renal clearance (Clr) decreases. With lower clearance, the body removes the drug more slowly, causing the elimination half-life to increase and overall exposure (AUC) at a given dose to rise. To keep the steady-state concentration (Css) at the desired level, you must lower the dose or extend the dosing interval (or do both). In short, renal impairment typically reduces clearance of renally eliminated drugs and requires dose or interval adjustments to maintain Css. Some drugs also have non-renal clearance channels, but the main point remains: diminished kidney function lowers clearance and can lead to accumulation if dosing isn’t adjusted.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy